Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer

By sjmartinez • November 3, 2023

Zelba H, Rabsteyn A, Bartsch O, Kyzirakos C, Kayser S, Seibold M, Harter J, Latzer P, Hadaschik D, Battke F, Golf A, Rettig MB, Biskup S. Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer. Front Immunol. 2023 Oct 18;14:1271449. doi: 10.3389/fimmu.2023.1271449. PMID: 37920460; PMCID: PMC10619716.

Tags: APC, Cardiology/Epi, Harbor UCLA, neoantigen, peptide, prostate cancer, Publications, Vaccination

Healthcare System Resilience and Adaptation: A 6-Year Analysis of Heart Failure Care in the Veterans Affairs System

Brownell NK, Inkelas M, Chen L, Leng M, Doan AAQ, Shannon E, Jackson N, Hsue P, Ong M, Yano E, Fonarow GC, Ziaeian B. Healthcare[...]

Association of ramus intermedius with greater overall coronary plaque and stenosis burden

Ansari S, Pourafkari L, Kinninger A, Budoff MJ. Association of ramus intermedius with greater overall coronary plaque and stenosis burden. Int J Cardiovasc Imaging. 2026[...]

Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

Hegde SM, Wang X, Bhatia A, Peña-Peña ML, Sherrid MV, Figueiredo EL, Arad M, Barriales-Villa R, Choudhury L, Claggett BL, Coats CJ, de Barros Correia[...]